Uranium Royalty Corp: Canaccord Lifts Price Target To $4.25

Uranium Royalty Corp (TSXV: URC) recently closed their C$37 million financing, allowing Canaccord Genuity to upgrade their price target from C$3.15 to C$4.25 while reiterating their Speculative Buy rating.

The company only has three analysts who cover the name, with a weighted 12-month price target of $4.20, a 9% upside. Two analysts have strong buy ratings while one analyst has a buy rating. The street high comes from Paradigm Capital with a C$4.75 price target and the lowest comes from H.C Wainwright with a C$3.60 price target.

Katie Lachapelle, Canaccord’s analyst says that Uranium Royalty is now cashed up and ready to execute. After the close of this raise, the company now has C$70 million in cash and equity investments. She writes, “URC is well-positioned to execute on future royalty, stream, and physical uranium transactions, building on its momentum year-to-date.” She calls Uranium the “only pure-play uranium royalty company,” and believes because of its uniqueness, it is positioned well to be a prime lender to uranium developers.

Altamira Gold Corp. — sponsored Sponsored · Altamira Gold Corp.

Canaccord recently upgraded their outlook on the uranium market and believe that its a, “hugely strategic metal whose value in a carbon-constrained world will only increase.” They believe that the current market leaders are under significant macro and micro pressures which will provide strong demand tailwinds for the smaller companies which will push the spot price up to U$60/lb.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Building the Next 500,000-Ounce Gold Producer | Stephen Soock – Heliostar Metals

This Gold Explorer Is Making Its Biggest Bet | Brian Miller – Astra Exploration

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

Xebec Adsorption: BMO Cuts Price Target To Just $0.85 After Poor Q2 Margins

Xebec Adsorption (TSX: XBC) yesterday announced its second quarter financial results. The company announced revenues...

Saturday, August 13, 2022, 03:04:00 PM

Cameco CFO Clears The Air With “Four Really Important Facts”

In a bid to dispel concerns surrounding Cameco’s (TSX: CCO) market pricing, CFO Grant Isaac...

Wednesday, March 6, 2024, 09:29:00 AM

Cognetivity: Echelon Raises Price Target To $1.50 After Biogen Approval

Monday was a very big day for companies who are in the business to help...

Wednesday, June 9, 2021, 11:22:00 AM

McDonalds: Analysts Estimate $1.59 Billion In Q2 Net Income

McDonalds Corp (NYSE: MCD) will be reporting their second quarter financials on July 28 before...

Tuesday, July 27, 2021, 05:43:00 PM

Canada Tops U.S. Uranium Deliveries in 2023 – EIA Report

In a recent report released by the U.S. Energy Information Administration (EIA), Canada emerged as...

Sunday, June 16, 2024, 01:25:00 PM